Evercore ISI analyst Elizabeth Anderson raised the firm’s price target on CVS Health to $85 from $80 and keeps an Outperform rating on the shares. Following the company’s investor day, Evercore says the firm liked the company’s new approach to guidance, which “conservatively” points to 6% EPS growth with the opportunity for upside in a variety of areas.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CVS: